1. Home
  2. ALGS vs LOAN Comparison

ALGS vs LOAN Comparison

Compare ALGS & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • LOAN
  • Stock Information
  • Founded
  • ALGS 2018
  • LOAN 1989
  • Country
  • ALGS United States
  • LOAN United States
  • Employees
  • ALGS N/A
  • LOAN N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • LOAN Real Estate Investment Trusts
  • Sector
  • ALGS Health Care
  • LOAN Real Estate
  • Exchange
  • ALGS Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • ALGS 50.4M
  • LOAN 58.1M
  • IPO Year
  • ALGS 2020
  • LOAN 1999
  • Fundamental
  • Price
  • ALGS $7.84
  • LOAN $5.87
  • Analyst Decision
  • ALGS Strong Buy
  • LOAN
  • Analyst Count
  • ALGS 1
  • LOAN 0
  • Target Price
  • ALGS $70.00
  • LOAN N/A
  • AVG Volume (30 Days)
  • ALGS 125.8K
  • LOAN 13.3K
  • Earning Date
  • ALGS 08-05-2025
  • LOAN 07-21-2025
  • Dividend Yield
  • ALGS N/A
  • LOAN 8.06%
  • EPS Growth
  • ALGS N/A
  • LOAN N/A
  • EPS
  • ALGS N/A
  • LOAN 0.48
  • Revenue
  • ALGS $3,270,000.00
  • LOAN $7,291,468.00
  • Revenue This Year
  • ALGS N/A
  • LOAN N/A
  • Revenue Next Year
  • ALGS $51.55
  • LOAN $4.41
  • P/E Ratio
  • ALGS N/A
  • LOAN $12.09
  • Revenue Growth
  • ALGS N/A
  • LOAN N/A
  • 52 Week Low
  • ALGS $3.76
  • LOAN $4.74
  • 52 Week High
  • ALGS $46.80
  • LOAN $6.05
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 57.02
  • LOAN 78.88
  • Support Level
  • ALGS $6.82
  • LOAN $5.12
  • Resistance Level
  • ALGS $8.66
  • LOAN $5.20
  • Average True Range (ATR)
  • ALGS 0.76
  • LOAN 0.11
  • MACD
  • ALGS -0.06
  • LOAN 0.06
  • Stochastic Oscillator
  • ALGS 55.49
  • LOAN 98.39

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: